CSIMarket
 
Kiromic Biopharma Inc   (KRBP)
 

KRBP's Market share relative to its competitors, as of Q4 2024

As of Q4 2024 (Revenue in Millions of $)

Date modified: 2026-05-18T05:46:34+00:00





COMPANY NAME REVENUES
12 Months Ending
Q4 2024
MARKET SHARE
12 Months
Q4 2024
MARKET SHARE
MRQ
Q4 2024
MARKET SHARE
A Quarter Before
Q3 2024
Kiromic Biopharma Inc 0.00 0.00% 0.00 % 0.00 %
Immunocore Holdings Plc 430.78 32.60% 19.97% 47.25%
Meiragtx Holdings Plc 397.50 30.08% 55.38% 0.13%
Iovance Biotherapeutics inc 324.97 24.59% 17.11% 31.64%
Bluebird Bio Inc 103.95 7.87% 6.67% 17.06%
Lenz Therapeutics Inc 21.48 1.63% 0.95% 0.84%
12 more competitors available

Sign in to see all competitors for Kiromic Biopharma Inc .




KRBP's Market share relative to its competitors, as of Q4 2024 within the Biotechnology & Pharmaceuticals Industry
As of Q4 2024



COMPANY NAME MARKET SHARE
12 Months Ending
Q4 2024
MARKET SHARE
12 Months Ending
Q3 2024
MARKET SHARE
MRQ
Q4 2024
MARKET SHARE

Q3 2024
Kiromic Biopharma Inc 0.00% 0.00% 0.00 % 0.00 %
Immunocore Holdings Plc 32.63% 40.56% 19.83% 47.25%
Meiragtx Holdings Plc 30.11% 8.25% 54.99% 0.13%
Iovance Biotherapeutics inc 24.62% 26.72% 16.99% 31.64%
Bluebird Bio Inc 7.87% 8.50% 6.62% 17.06%
Lenz Therapeutics Inc 1.63% 0.00% 0.94% 0.84%
11 more companies available

Sign in to see all industry competitors for Kiromic Biopharma Inc .




KRBP's Market share relative to its competitors, as of Q4 2024 within the Healthcare Sector
As of Q4 2024



COMPANY NAME MARKET SHARE
12 Months Ending
Q4 2024
MARKET SHARE
12 Months Ending
Q3 2024
MARKET SHARE
MRQ
Q4 2024
MARKET SHARE

Q3 2024
Kiromic Biopharma Inc 0.00% 0.00% 0.00 % 0.00 %
Immunocore Holdings Plc 32.63% 40.56% 19.83% 47.25%
Meiragtx Holdings Plc 30.11% 8.25% 54.99% 0.13%
Iovance Biotherapeutics inc 24.62% 26.72% 16.99% 31.64%
Bluebird Bio Inc 7.87% 8.50% 6.62% 17.06%
Lenz Therapeutics Inc 1.63% 0.00% 0.94% 0.84%
11 more companies available

Sign in to see all sector competitors for Kiromic Biopharma Inc .




Note: Market share is calculated based on total revenue. To get a more accurate picture of Kiromic Biopharma Inc's market divisions, geographic dispersion, segments, products, and services, visit Kiromic Biopharma Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.